Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Clusterin in Alzheimer's disease.

Wu ZC, Yu JT, Li Y, Tan L.

Adv Clin Chem. 2012;56:155-73. Review.

PMID:
22397031
2.

Clusterin: a forgotten player in Alzheimer's disease.

Nuutinen T, Suuronen T, Kauppinen A, Salminen A.

Brain Res Rev. 2009 Oct;61(2):89-104. doi: 10.1016/j.brainresrev.2009.05.007. Epub 2009 Aug 3. Review.

PMID:
19651157
3.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. Review.

PMID:
21143138
4.

Apolipoprotein J (clusterin) and Alzheimer's disease.

Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J.

Microsc Res Tech. 2000 Aug 15;50(4):305-15. Review.

PMID:
10936885
6.

Relationship between multifunctional protein "clusterin" and Alzheimer disease.

Choi-Miura NH, Oda T.

Neurobiol Aging. 1996 Sep-Oct;17(5):717-22. Review.

PMID:
8892344
7.

Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta.

Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J, Zhao Z.

Neurosci Bull. 2014 Feb;30(1):162-8. doi: 10.1007/s12264-013-1391-2. Epub 2013 Dec 19. Review.

8.

Relationship between genetic risk factors and markers for Alzheimer's disease pathology.

Elias-Sonnenschein LS, Bertram L, Visser PJ.

Biomark Med. 2012 Aug;6(4):477-95. doi: 10.2217/bmm.12.56. Review.

PMID:
22917148
9.

Mitochondrial dysfunction and Alzheimer's disease.

Maruszak A, Żekanowski C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16. Review.

PMID:
20624441
10.

Alzheimer's disease: the cholesterol connection.

Puglielli L, Tanzi RE, Kovacs DM.

Nat Neurosci. 2003 Apr;6(4):345-51. Review.

PMID:
12658281
11.

Clusterin and Alzheimer's disease.

Calero M, Rostagno A, Frangione B, Ghiso J.

Subcell Biochem. 2005;38:273-98. Review.

PMID:
15709484
12.

Cholesterol, lipids, amyloid Beta, and Alzheimer's.

Vestergaard M, Hamada T, Morita M, Takagi M.

Curr Alzheimer Res. 2010 May;7(3):262-70. Review.

PMID:
19715550
14.

Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease.

Posse de Chaves E.

Can J Physiol Pharmacol. 2012 Jun;90(6):753-64. doi: 10.1139/y2012-076. Epub 2012 May 24. Review.

PMID:
22626060
15.

The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Yu JT, Tan L.

Mol Neurobiol. 2012 Apr;45(2):314-26. doi: 10.1007/s12035-012-8237-1. Epub 2012 Jan 25. Review.

PMID:
22274961
16.

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

Butterfield DA, Castegna A, Lauderback CM, Drake J.

Neurobiol Aging. 2002 Sep-Oct;23(5):655-64. Review.

PMID:
12392766
17.

Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?

Watt AD, Villemagne VL, Barnham KJ.

J Alzheimers Dis. 2013;33 Suppl 1:S283-93. doi: 10.3233/JAD-2012-129017. Review.

PMID:
22699851
18.

The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.

Iurescia S, Fioretti D, Mangialasche F, Rinaldi M.

J Alzheimers Dis. 2010;21(1):35-48. doi: 10.3233/JAD-2010-100009. Review.

PMID:
20182014
19.

Pathological significance of ganglioside clusters in Alzheimer's disease.

Yanagisawa K.

J Neurochem. 2011 Mar;116(5):806-12. doi: 10.1111/j.1471-4159.2010.07006.x. Epub 2011 Jan 7. Review.

20.

APOE and cholesterol homeostasis in Alzheimer's disease.

Leduc V, Jasmin-Bélanger S, Poirier J.

Trends Mol Med. 2010 Oct;16(10):469-77. doi: 10.1016/j.molmed.2010.07.008. Review.

PMID:
20817608

Supplemental Content

Support Center